Floatz logo

Therapeutic Asset Ratings

344 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Ketorolac Tromethamine
plasma cell myeloma
SanofiP3B (58)
Panobinostat
plasma cell myeloma
Abdullah KhanP3B (58)
PEGFILGRASTIM
plasma cell myeloma
The Affiliated People's Hospital of Ningbo UniversityP3B (58)
Pembrolizumab
plasma cell myeloma
Andrew Hantel, MDP3B (58)
ql2109
plasma cell myeloma
Qilu Pharmaceutical Co., Ltd.P3B (58)
Bcma Car-T Cells
plasma cell myeloma
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP2B (58)
Carboplatin
Multiple Myeloma
Andrew Hantel, MDP2B (58)
Chimeric Antigen Receptor Modified T Cells Infusion
Multiple Myeloma
Centre Hospitalier Universitaire de Saint EtienneP2B (58)
Ruxolitinib
plasma cell myeloma
OncotherapeuticsP2B (58)
HYDROMORPHON
Multiple Myeloma
SanofiP3B (57)
gsk1120212
plasma cell myeloma
Cancer Research UKP2/3B (57)
Clarithromycin
plasma cell myeloma
Weill Medical College of Cornell UniversityP3B (56)
Vorinostat
plasma cell myeloma
OHSU Knight Cancer InstituteP3B (56)
Atezolizumab
plasma cell myeloma
Genentech, Inc.P2B (56)
Azacitidine
plasma cell myeloma
Sumitomo Pharma America, Inc.P2B (56)
Temsirolimus
plasma cell myeloma
Canadian Cancer Trials GroupP2B (56)
VEMURAFENIB
plasma cell myeloma
Cancer Research UKP2/3B (56)
Fenofibrate
plasma cell myeloma
Tanta UniversityP4CCC (55)
Abemaciclib
plasma cell myeloma
OHSU Knight Cancer InstituteP2CCC (55)
Clofarabine
plasma cell myeloma
M.D. Anderson Cancer CenterP2CCC (55)
Ipilimumab
plasma cell myeloma
OHSU Knight Cancer InstituteP2CCC (55)
Vesanoid
plasma cell myeloma
The Methodist Hospital Research InstituteP2CCC (55)
Cobimetinib
plasma cell myeloma
Cancer Research UKP2/3CCC (55)
Famotidine
plasma cell myeloma
Emory UniversityP4CCC (54)
Pentaisomaltose
plasma cell myeloma
Pharmacosmos A/SP4CCC (54)
Showing 76 to 100 of 344 assets
PreviousPage 4 of 14Next